• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对比分析抗线粒体抗体阳性与抗线粒体抗体阴性原发性胆汁性肝硬化的门管区炎症细胞浸润。

Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody-positive versus antimitochondrial autoantibody-negative primary biliary cirrhosis.

机构信息

First Hospital, University of Jilin, Changchun, China.

出版信息

Hepatology. 2012 May;55(5):1495-506. doi: 10.1002/hep.25511. Epub 2012 Apr 4.

DOI:10.1002/hep.25511
PMID:22135136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3299932/
Abstract

UNLABELLED

Substantial evidence supports dysregulated B-cell immune responses in patients with primary biliary cirrhosis (PBC), including the presence of serum antimitochondrial antibodies (AMAs). However, recent reports from murine models of PBC suggest that B cells may also provide regulatory function, and indeed the absence of B cells in such models leads to exacerbation of disease. The vast majority of patients with PBC have readily detectable AMAs, but a minority (<5%) are AMA negative (AMA(-)), even with recombinant diagnostic technology. This issue prompted us to examine the nature of B-cell infiltrates surrounding the portal areas in AMA-positive (AMA(+)) and AMA(-) patients, because they display indistinguishable clinical features. Of importance was the finding that the degree of bile duct damage around the portal areas was significantly milder in AMA(+) PBC than those observed in AMA(-) PBC patients. The portal areas from AMA(-) patients had a significant increase of cluster of differentiation (CD)5(+) cells infiltrating the ductal regions, and the levels of B-cell infiltrates were worse in the early phase of bile duct damage. The frequency of positive portal areas and the magnitude of CD5(+) and CD20(+) cellular infiltrates within areas of ductal invasion is associated with the first evidence of damage of biliary duct epithelia, but becomes reduced in the ductopenia stage, with the exception of CD5(+) cells, which remain sustained and predominate over CD20(+) cells.

CONCLUSION

Our data suggest a putative role of B-cell autoimmunity in regulating the portal destruction characteristic of PBC.

摘要

未注明

大量证据表明原发性胆汁性肝硬化 (PBC) 患者的 B 细胞免疫反应失调,包括血清抗线粒体抗体 (AMA) 的存在。然而,来自 PBC 鼠模型的最新报告表明,B 细胞也可能提供调节功能,事实上,此类模型中 B 细胞的缺失会导致疾病恶化。绝大多数 PBC 患者都有可检测到的 AMA,但少数 (<5%) 为 AMA 阴性 (AMA(-)),即使使用重组诊断技术也是如此。这个问题促使我们检查 AMA 阳性 (AMA(+)) 和 AMA(-) 患者门脉周围 B 细胞浸润的性质,因为它们表现出无法区分的临床特征。重要的是发现,与 AMA(-) PBC 患者相比,AMA(+) PBC 患者门脉周围胆管损伤的程度明显较轻。AMA(-) PBC 患者的门脉区域有明显更多的 CD5(+)细胞浸润到胆管区域,并且在胆管损伤的早期阶段 B 细胞浸润程度更严重。阳性门脉区域的频率以及胆管浸润区域内 CD5(+)和 CD20(+)细胞的浸润程度与胆管上皮损伤的第一个证据相关,但在胆管减少阶段减少,除了 CD5(+)细胞,其持续存在并超过 CD20(+)细胞占主导地位。

结论

我们的数据表明 B 细胞自身免疫在调节 PBC 的门脉破坏特征中具有潜在作用。

相似文献

1
Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody-positive versus antimitochondrial autoantibody-negative primary biliary cirrhosis.对比分析抗线粒体抗体阳性与抗线粒体抗体阴性原发性胆汁性肝硬化的门管区炎症细胞浸润。
Hepatology. 2012 May;55(5):1495-506. doi: 10.1002/hep.25511. Epub 2012 Apr 4.
2
Clinicopathological study of primary biliary cirrhosis negative for antimitochondrial antibodies.抗线粒体抗体阴性的原发性胆汁性肝硬化的临床病理研究
Liver. 1997 Dec;17(6):281-7. doi: 10.1111/j.1600-0676.1997.tb01033.x.
3
Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis.新型增强性能M2(MIT3)酶联免疫吸附测定法检测原发性胆汁性肝硬化中IgA和IgG抗线粒体抗体的诊断相关性及临床意义
J Clin Immunol. 2007 Jul;27(4):378-87. doi: 10.1007/s10875-007-9092-0. Epub 2007 May 21.
4
Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis.抗线粒体抗体阴性的原发性胆汁性肝硬化:原发性胆汁性肝硬化的一个亚组
Liver Int. 2008 Feb;28(2):233-9. doi: 10.1111/j.1478-3231.2007.01651.x.
5
A sensitive bead assay for antimitochondrial antibodies: Chipping away at AMA-negative primary biliary cirrhosis.一种用于抗线粒体抗体的灵敏微珠检测法:逐步攻克AMA阴性的原发性胆汁性肝硬化。
Hepatology. 2007 Mar;45(3):659-65. doi: 10.1002/hep.21583.
6
Primary biliary cirrhosis in antimitochondrial antibody-negative patients: Chang Gung Memorial Hospital experience.抗线粒体抗体阴性患者的原发性胆汁性肝硬化:长庚纪念医院经验
Chang Gung Med J. 2003 May;26(5):323-9.
7
Infiltration of inflammatory cells expressing mitochondrial proteins around bile ducts and in biliary epithelial layer may be involved in the pathogenesis in primary biliary cirrhosis.炎症细胞浸润胆管周围和胆管上皮层,表达线粒体蛋白,可能参与原发性胆汁性肝硬化的发病机制。
J Clin Pathol. 2014 Jun;67(6):470-6. doi: 10.1136/jclinpath-2013-201917. Epub 2014 Jan 9.
8
Characterization of overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis according to antimitochondrial antibodies status.根据抗线粒体抗体状态对原发性胆汁性肝硬化与自身免疫性肝炎重叠综合征的特征分析。
Gastroenterol Clin Biol. 2007 Jan;31(1):11-6. doi: 10.1016/s0399-8320(07)89322-5.
9
Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis.抗线粒体抗体阴性原发性胆汁性肝硬化:一种自身免疫性胆管炎的独特综合征。
Gut. 1994 Feb;35(2):260-5. doi: 10.1136/gut.35.2.260.
10
Clinical evaluation of serum antimitochondrial antibody-negative primary biliary cirrhosis.血清抗线粒体抗体阴性原发性胆汁性肝硬化的临床评估
Hepatobiliary Pancreat Dis Int. 2004 May;3(2):288-91.

引用本文的文献

1
The Role of Inflammation in Cholestatic Liver Injury.炎症在胆汁淤积性肝损伤中的作用。
J Inflamm Res. 2023 Oct 13;16:4527-4540. doi: 10.2147/JIR.S430730. eCollection 2023.
2
Primary biliary cholangitis: molecular pathogenesis perspectives and therapeutic potential of natural products.原发性胆汁性胆管炎:天然产物的分子发病机制研究进展与治疗潜力。
Front Immunol. 2023 Jun 30;14:1164202. doi: 10.3389/fimmu.2023.1164202. eCollection 2023.
3
Role of autoantibodies in the clinical management of primary biliary cholangitis.自身抗体在原发性胆汁性胆管炎临床管理中的作用。
World J Gastroenterol. 2023 Mar 28;29(12):1795-1810. doi: 10.3748/wjg.v29.i12.1795.
4
Guidelines on the Diagnosis and Management of Primary Biliary Cholangitis (2021).原发性胆汁性胆管炎的诊断与管理指南(2021年)
J Clin Transl Hepatol. 2023 Jun 28;11(3):736-746. doi: 10.14218/JCTH.2022.00347. Epub 2023 Feb 10.
5
Distinction between Mitochondrial Antibody-Positive and -Negative Primary Biliary Cholangitis.线粒体抗体阳性与阴性原发性胆汁性胆管炎的鉴别
Case Rep Gastroenterol. 2023 Jan 6;17(1):14-20. doi: 10.1159/000528437. eCollection 2023 Jan-Dec.
6
APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis.亚太肝脏研究学会临床实践指南:原发性胆汁性胆管炎患者的诊断与管理
Hepatol Int. 2022 Feb;16(1):1-23. doi: 10.1007/s12072-021-10276-6. Epub 2022 Feb 4.
7
An enhanced level of LAMP-2A participates in CD4T cell hyperactivity in patients with primary biliary cholangitis.原发性胆汁性胆管炎患者中,LAMP-2A水平升高参与CD4⁺T细胞的过度活化。
Ann Transl Med. 2021 Jan;9(2):101. doi: 10.21037/atm-20-2427.
8
Emperipolesis mediated by CD8 T cells correlates with biliary epithelia cell injury in primary biliary cholangitis.CD8 T 细胞介导的胞质易位与原发性胆汁性胆管炎中胆管上皮细胞损伤相关。
J Cell Mol Med. 2020 Jan;24(2):1268-1275. doi: 10.1111/jcmm.14752. Epub 2019 Dec 18.
9
Anti-drug Antibodies Against a Novel Humanized Anti-CD20 Antibody Impair Its Therapeutic Effect on Primary Biliary Cholangitis in Human CD20- and FcγR-Expressing Mice.抗新型人源化抗 CD20 抗体可损害其在人 CD20 和 FcγR 表达小鼠原发性胆汁性胆管炎中的治疗作用。
Front Immunol. 2018 Nov 2;9:2534. doi: 10.3389/fimmu.2018.02534. eCollection 2018.
10
Exploring pathogenesis of primary biliary cholangitis by proteomics: A pilot study.采用蛋白质组学探索原发性胆汁性胆管炎发病机制:一项初步研究。
World J Gastroenterol. 2017 Dec 28;23(48):8489-8499. doi: 10.3748/wjg.v23.i48.8489.

本文引用的文献

1
Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis.胆汁抗原和抗线粒体抗体激活原发性胆汁性肝硬化中的固有免疫反应。
Hepatology. 2010 Sep;52(3):987-98. doi: 10.1002/hep.23783.
2
B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice.在转化生长因子-β受体II显性阴性小鼠中,抗CD20介导的B细胞耗竭改善了自身免疫性胆管炎,但加剧了结肠炎。
Hepatology. 2009 Dec;50(6):1893-903. doi: 10.1002/hep.23238.
3
IL-10 production by B cells expressing CD5 with the alternative exon 1B.表达带有可变外显子1B的CD5的B细胞产生白细胞介素-10 。
Ann N Y Acad Sci. 2009 Sep;1173:280-5. doi: 10.1111/j.1749-6632.2009.04616.x.
4
Differential susceptibility of peripheral blood CD5+ and CD5- B cells to apoptosis in chronic hepatitis C patients.慢性丙型肝炎患者外周血CD5 +和CD5 - B细胞对凋亡的易感性差异
Biochem Biophys Res Commun. 2009 Nov 20;389(3):512-5. doi: 10.1016/j.bbrc.2009.09.012. Epub 2009 Sep 6.
5
Primary biliary cirrhosis.原发性胆汁性肝硬化
Hepatology. 2009 Jul;50(1):291-308. doi: 10.1002/hep.22906.
6
New ELISA for detecting primary biliary cirrhosis-specific antimitochondrial antibodies.用于检测原发性胆汁性肝硬化特异性抗线粒体抗体的新型酶联免疫吸附测定法。
Clin Chem. 2009 May;55(5):978-85. doi: 10.1373/clinchem.2008.118299. Epub 2009 Mar 5.
7
Apotopes and the biliary specificity of primary biliary cirrhosis.表位与原发性胆汁性肝硬化的胆汁特异性
Hepatology. 2009 Mar;49(3):871-9. doi: 10.1002/hep.22736.
8
CD5: a safeguard against autoimmunity and a shield for cancer cells.CD5:自身免疫的防护机制及癌细胞的保护伞。
Autoimmun Rev. 2009 Feb;8(4):349-53. doi: 10.1016/j.autrev.2008.11.007. Epub 2008 Nov 27.
9
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression.调节性B细胞可抑制小鼠实验性自身免疫性脑脊髓炎的发病,而其他B细胞则会促进疾病进展。
J Clin Invest. 2008 Oct;118(10):3420-30. doi: 10.1172/JCI36030.
10
Regulatory B cells as inhibitors of immune responses and inflammation.调节性B细胞作为免疫反应和炎症的抑制剂。
Immunol Rev. 2008 Aug;224:201-14. doi: 10.1111/j.1600-065X.2008.00661.x.